Dr Steven MacLennan

Dr Steven MacLennan
Dr Steven MacLennan
Dr Steven MacLennan

Senior Research Fellow

About
Email Address
steven.maclennan@abdn.ac.uk
Telephone Number
+44 (0)1224 438123
Office Address

Academic Urology Unit Health Sciences Building (2nd Floor) University of Aberdeen Foresterhill Aberdeen AB25 2ZD Tel: +44 (0)1224 559086 Fax: +44 (0)1224 554580 Email: steven.maclennan@abdn.ac.uk

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

Steven is a Research Fellow in the Academic Urology Unit at the University of Aberdeen. His research themes cover the broad spectrum of evidence-based medicine in urology. This encompasses assessing the effectiveness of treatments in clinical trials, developing core outcome sets, providing critical reviews of the evidence base, creating evidence-based (or where necessary consensus-based) clinical practice guidelines, and implementing guideline recommendations in clinical practice. Steven is a member of the European Association of Urology (EAU) methodology committee which oversees the quality of the EAU’s systematic review and clinical practice guideline programme and delivers training on core evidence-based medicine skills in systematic reviews and guideline production. He is also a founding member of the IMpact Assessment of Guidelines Implementation and Education (IMAGINE) group which aims to assess current variations in practice, investigate barriers and facilitators to guideline adherent practice, and improve adherence to strong, high level of evidence, guideline recommendations. Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope (PIONEER) is one of Steven’s recent projects, where his heaviest involvement is in the work to help standardise outcome definitions across all stages of disease to support the Big Data analysis work and improve the consistency of outcome reporting, outcome definition and measurement in future clinical trials and clinical audit.

Qualifications

  • PhD Sociology 
    2010 - University of Edinburgh 
  • MRes Social Research Methods 
    2006 - University of Aberdeen 
  • BA (Hons.) Applied Social Science 
    2005 - The Robert Gordon University 

Memberships and Affiliations

Internal Memberships

IAHS Athena Swan Self Assessment Team 

External Memberships

European Association of Urology

Research

Research Overview

An overview of current projects: 

Core Outcome Set Development Projects

Renal Cancer Core Outcome Sets (R-COS)

In this project, part funded by the Arcobaleno Cancer Trust and NHS Grampian Endowments, we are developing three seperate Core Outcome Sets (COS) for localised, locally advanced, and metastatic stages of kidney cancer. This includes two systematic reviews, an interview study and three Delphi studies. The COMET registration, giving full study details is accessible here: https://www.comet-initiative.org/studies/details/1406  

Bladder Cancer Core Outcome Sets (B-COS) 

In this project, we are developing Core Outcome Sets for the various stages of bladder cancer. Forming the initial statge of the project, we published an article reviewing outcome reporting heterogeneity in non-muscle invasive bladder cancer - accessible here: https://content.iospress.com/articles/bladder-cancer/blc201510

The COMET registration, giving full study details is availabe here: https://www.comet-initiative.org/studies/details/1135

Prostate Cancer Core Outcome Sets

We devleoped a COS for localised prostate cancer. The results can be accessed here: https://bjui-journals.onlinelibrary.wiley.com/doi/abs/10.1111/bju.13854

Our prostate cancer COS work was subsequently updated and incorporated in the PIONEER project. More detail about PIONEER can be viewed here: https://prostate-pioneer.eu/

 

Implementation Science Projects

IMAGINE (IMpact Assessment of Guidelines Implementation and Education)

IMAGINE is a European Association of Urology (EAU) working group focussing on  mapping adherence to EAU guidelines and, where variation or suboptimal practice is identified, investigating the barriers and facilitators to guideline adherence, and developing implementation interventions to adress the barriers and leverage the facilitators. You can read more about the IMAGINE group in this editorial

RESECT (Transurethral REsection and Single instillation intra-vesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT) Improving quality in TURBT surgery.)

RESECT is a collaborative project with the British Urology Researchers in Surgical Training (BURST) group, including researchers from the Academic Urology Unit and HSRU. A main aim of RESECT is to test intereventions aimed at improving adherence to guidelines around single instilation of chemotherapy adn documentation of the procudure - which have been shown to be associated with improved patient outcomes. You can read more about RESECT here: https://www.bursturology.com/Studies/Resect/Overview/

OPTIMA (OPtimal Treatment for patients wiht solid tumours in Europe through Artificial Intelligence)

OPTIMA is a 34 partners-based  IMI project. The programme aim is to design, develop and deliver the first interoperable and GDPR-compliant European real-world oncology data and evidence generation platform based on the needs of the clinicians and patients, in an inclusive and sustainable way. It will be built on a combination of federated and centralised access to a vast network of European data providers to help answer the highest priority research questions in prostate, breast and lung cancer, especially where current existing evidence underpinning clinical practice guidelines is weak.  In parallel, comprehensive decision support toolsets based on national and international guidelines with approved regular updates of guideline recommendations underpinned by evidence from advanced statistical analysis and AI will be made available to fill the guidelines gaps and better support shared decision making by clinicians and patients.

Deimplementing ADT

There is evidence to suggest that Androgen Deprivation Therapy (ADT) is overused in men with localised prostate cancer. it is unclear why, and it is unclear what the best strategies for deimplementing ADT are. This reserach problem is the focus of Jennifer Dunsmore's PhD project, which Steven is supervising. You can read more about Jennifer and her reserach here: https://www.abdn.ac.uk/iahs/research/urology/metis/profiles/j.dunsmore.19

Guideline Development Projects 

Steven sits on the European Association of Urology (EAU) Guidelines Office Methodology Committee. This committee oversees the training of Guidelines Associates through Systematic Review workshops. 

EVOLVE (giving patients a meaningful voice in the design and delivery of care)

EVOLVE is a unique collaboration of a profession society (European Association of Urology), guideline panels, researchers, clinicians and patient representatives to improve guideline development and implementation for genitourinary cancers in Europe.  The aim of the project is to develop a model of patient involvement that will give patients a meaningful voice in the design and delivery of care and will investigate how wider stakeholders can help to integrate the patient voice into guidelines. You can read more about EVOLVE here: https://www.abdn.ac.uk/iahs/research/urology/metis/evolve-1618.php

 

Teaching

Teaching Responsibilities

Steven contributes to the design, delivery and assessment of the MSc. level courses in the Institute of Applied Health Sciences linked above. He also supervises MSc. dissertations and often supervises medical student summer placements in the Aberdeen Summer Research Scholarship (ASRS) programme. 

Steven currently supervises two PhD. projects and is intersted in supervising any project aligning with his broad interests in the desing and delivery of urology health services.   

Non-course Teaching Responsibilities

Alongside formal teaching at the University of Aberdeen, Steven and his colleagues also developed a 2.5 day course for the European Association of Urology (EAU) on systematic reviews for clinical practice guidelines. 

Steven also teaches the systematic review element for the European Organisaiton for Research and Treatment of Cancer (EORTC) 'clinical trial statistics for non-statisticians' course. https://event.eortc.org/stats2021/

Publications

Page 1 of 3 Results 1 to 50 of 145

  • AGREE II Quality assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium

    Sakalis, V., Bhattacharya, Y., Beyer, K., Murray, C., Smith, E. J., Willemse, P. M., Gandaglia, G., Boissier, R., Borkowetz, A., Dabestani, S., eenen, R. C. L., Vilaseca, A., Maresca, G., Teoh, J. Y., Gómez Rivas, J., Rajwa, P., Lardas, M., Grivas, N., van den Broeck, T., Pradere, B., Schouten, N., Tandogdu, Z., Evans-Axelsson, S., MacLennan, S., Thomas, M., Briganti, A., Bjartell, A., Cornford, P., Kruger, H., N’Dow, J., Roobol, M. J., Omar, M. I., OPTIMA Consortium
    European Urology Open Science, vol. 70, pp. 183-193
    Contributions to Journals: Articles
  • Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021

    Barclay, N. L., Burn, E., Delmestri, A., Duarte-Salles, T., Golozar, A., Man, W. Y., Tan, E. H., Tietzova, I., OPTIMA Consortium, Prieto-Alhambra, D., Newby, D., Anderson, L., MacLennan, S., MacLennan, S., Speirs, V., Zibaite, S., Boyle, M., Murray, C., McDonald, D.
    Scientific Reports, vol. 14, 19069
    Contributions to Journals: Articles
  • Specifying behavioural and strategy components of de-implementation efforts targeting low-value prescribing practices in secondary health care

    Dunsmore, J., Duncan, E., MacLennan, S., N'Dow, J., MacLennan, S.
    Implementation Science Communications, vol. 5, no. 1, 88
    Contributions to Journals: Articles
  • Influences on Androgen Deprivation Therapy prescribing before surgery in high-risk prostate cancer

    Dunsmore, J., MacLennan, S., N'Dow, J., Cornford, P., Esperto, F., Pavan, N., Ribal, M. J., Roobol, M., Skolarus, T. A., MacLennan, S.
    BJUI Compass
    Contributions to Journals: Articles
  • Unpacking overuse of androgen deprivation therapy for prostate cancer to inform de-implementation strategies

    Skolarus, T. A., Hawley, S. T., Forman, J., Sales, A. E., Sparks, J. B., Metreger, T., Burns, J., Caram, M. V., Radhakrishnan, A., Dossett, L. A., Makarov, D. V., Leppert, J. T., Shelton, J. B., Stensland, K. D., Dunsmore, J., Maclennan, S., Saini, S., Hollenbeck, B. K., Shahinian, V., Wittmann, D. A., Deolankar, V., Sriram, S.
    Implementation Science Communications, vol. 5, 37
    Contributions to Journals: Articles
  • AGREE II quality assessment of national and international clinical practice guidelines on prostate cancer

    Beyer, K., Bhattacharya, Y., Murray, C., Smith, E., Boissier, R., Borkowetz, A., Dabestani, S., Willemse, P. M., Maresca, G., Gómez Rivas, J., Rajwa, P., Lardas, M., Grivas, N., Sakalis, V. I., Evans-Axelsson, S., MacLennan, S., Auweter, S., Thomas, M., Bjartell, A., Cornford, P., Kruger, H. S., N'Dow, J., Roobol, M. J., Omar, M. I.
    39th Annual EAU Congress
    Contributions to Conferences: Abstracts
  • Critical appraisal of systematic reviews cross-referenced by the European Association of Urology (EAU) 2023 Guidelines on prostate cancer 2023 with AMSTAR 2 tool

    Alebraheem, A., Imran, A., Cheriyan, A., MacLennan, S., Omar, M. I.
    39th Annual EAU Congress
    Contributions to Conferences: Abstracts
  • Development of Prostate Cancer Typical Case Presentations and Their Usage in OPTIMA’s Guideline Based Decision Support Tool

    Murray, C., Beyer, K., Gandaglia, G., Stabile, A., Auweter, S., Morariu, A., Santiago, I., MacLennan, S., MacLennan, S., Thomas, M., Bjartell, A., Cornford, P., Kruger, H. S., N'Dow, J., Roobol, M., Omar, M. I.
    39th Annual EAU Congress
    Contributions to Conferences: Abstracts
  • OPTIMA Prostate Cancer Care pathways: Bridging Clinical Practice Guidelines, Real World Evidence and Artificial Intelligence to Enhance Decision- Making

    Anselmo da Costa Santiago, I., Gómez Rivas, J., MacLennan, S., Beyer, K., Murray, C., Smith, E. J., Auweter, S., Thomas, M., Kruger, H. S., N'Dow, J., Bjartell, A., Cornford, P., Roobol, M. J., Omar, M. I.
    39th Annual EAU Congress
    Contributions to Conferences: Abstracts
  • How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?

    Beyer, K., Lawlor, A., Remmers, S., Bezuidenhout, C., Gómez Rivas, J., Venderbos, L. D. F., Smith, E. J., Gandaglia, G., MacLennan, S., MacLennan, S. J., Bjartell, A., Briganti, A., Cornford, P., Evans-Axelsson, S., Ribal, M. J., N'Dow, J., Briers, E., Roobol, M. J., Van Hemelrijck, M., PIONEER Consortium
    European Urology Open Science, vol. 62, pp. 1-7
    Contributions to Journals: Articles
  • Reply to Badar M. Mian. Prostate Biopsy: Hyperbole and Misrepresentation Versus Scientific Evidence and Equipoise. Eur Urol. 2024;85:99–100

    Pilatz, A., MacLennan, S., van den Bergh, R. C., Veeratterapillay, R., Omar, M. I., Yuan, Y., Cornford, P., Bonkat, G.
    European Urology, vol. 85, no. 3, pp. 313-314
    Contributions to Journals: Editorials
  • Standardising Patient-Reported Outcomes in Prostate Cancer: Insights from the PIONEER Consortium

    Beyer, K., Lardas, M., Ratti, M. M., Gandaglia, G., Omar, M. I., Tripathee, S., Venderbos, L. D., van den Broeck, T., Willemse, P. M., Antunes-Lopes, T., Pacheco-Figueiredo, L., Monagas Arteaga, S., Esperto, F., Flaherty, S., Devecseri, Z., Lam, T. B., Furnari, F., Mazzoleni Ferracini, S., Pellegrino, F., Sorce, G., Scuderi, S., Williamson, P. R., Smith, E. J., Moss, C., Barletta, F., Alleva, E., Sisca, E. S., Derevianko, A., Asiimwe, A., Huber, J., Roobol, M. J., Zong, J., Cornford, P., Mottet, N., MacLennan, S., Briganti, A., N'Dow, J., MacLennan, S., Moris, L., Van Hemelrijck, M.
    ISOQOL 2024
    Contributions to Conferences: Abstracts
  • The EANM Focus 5 consensus on 'molecular imaging and theranostics in prostate cancer': the future begins today

    Oprea-Lager, D., MacLennan, S., Dierckx, R., Fanti, S.
    European Journal of Nuclear Medicine and Molecular Imaging
    Contributions to Journals: Editorials
  • European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer

    Oprea-Lager, D., MacLennan, S., Bjartell, A., Briganti, A., Burger, I. A., de Jong, I., De Santis, M., Eberlein, U., Emmett, L., Fizazi, K., Gillessen, S., Herrmann, K., Heskamp, S., Iagaru, A., Jereczek-Fossa, B. A., Kunikowska, J., Lam, M., Nanni, C., O'Sullivan, J. M., Panebianco, V., Sala, E., Sathekge, M., Sosnowski, R., Tilki, D., Tombal, B., Treglia, G., Tunariu, N., Walz, J., Yakar, D., Dierckx, R., Sartor, O., Fanti, S.
    European Urology, vol. 85, no. 1, pp. 49-60
    Contributions to Journals: Articles
  • Survivorship data in Prostate Cancer: Where are we and where do we need to be?

    Russell, B., Beyer, K., Lawlor, A., Roobol, M. J., Venderbos, L. D., Remmers, S., Briers, E., MacLennan, S. J., MacLennan, S., Omar, M. I., Van Hemelrijck, M., PIONEER Consortium
    European Urology Open Science, vol. 59, pp. 27-29
    Contributions to Journals: Comments and Debates
  • En bloc resection of bladder tumour: the rebirth of past through reminiscence

    Teoh, J. Y., D'Andrea, D., Gallioli, A., Yanagisawa, T., MacLennan, S., Nicoletti, R., Fai, N. C., Maffei, D., Hurle, R., Lusuardi, L., Malavaud, B., Miki, J., Kramer, M., Mostafid, H., Enikeev, D., Babjuk, M., Breda, A., Shariat, S., Gontero, P., Herrmann, T.
    World Journal of Urology, vol. 41, no. 10, pp. 2599-2606
    Contributions to Journals: Review articles
  • Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review

    Dunsmore, J., Duncan, E., MacLennan, S., N’Dow, J., MacLennan, S.
    Implementation Science Communications, vol. 4, 115
    Contributions to Journals: Articles
  • A protocol for the development of Core Outcome Sets for effectiveness trials and clinical audits in Renal Cell Cancer (R-COS)

    MacLennan, S., Winter, L. M., Beyer, K., Lawlor, A., Tripathee, S., Dabestani, S., Marconi, L., Giles, R. H., Woodward, R., Bex, A., Zondervan, P.
    BJU International, vol. 4, no. 5, pp. 504-512
    Contributions to Journals: Articles
  • Unanswered questions in prostate cancer: Findings of an international multi-stakeholder consensus by the PIONEER Consortium

    Omar, M. I., MacLennan, S., Ribal, M. J., Roobol, M. J., Dimitropoulos, K., van den Broeck, T., MacLennan, S., Evans-Axelsson, S., Gandaglia, G., Willemse, P. M., Mastris, K., Butler-Ransohoff, J., Devecseri, Z., Abbott, T., De Meulder, B., Bjartell, A., Asiimwe, A., N'Dow, J.
    Nature reviews. Urology, vol. 20, pp. 494–501
    Contributions to Journals: Articles
  • The need for core outcome sets in renal cancer clinical effectiveness research

    MacLennan, S., Wintner, L. M., Omar, M. I., Beyer, K., Lawlor, A., Tripathee, S., Dabestani, S., Marconi, L., Giles, R. H., Woodward, R., Van Hemelrijck, M., Bex, A., Zondervan, P.
    Mini-invasive Surgery, vol. 7, 23
    Contributions to Journals: Editorials
  • Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized Trial

    Gallagher, K., Bhatt, N., Clement, K., Zimmermann, E., Khadhouri, S., MacLennan, S., Kulkarni, M., Gaba, F., Anbarasan, T., Asif, A., Light, A., Ng, A., Chan, V., Nathan, A., Cooper, D., Aucott, L., Marcq, G., Teoh, J. Y., Hensley, P., Duncan, E., Goulao, B., O'Brien, T., Nielsen, M., Mariappan, P., Kasivisvanathan, V.
    JMIR Research Protocols, vol. 12, e42254
    Contributions to Journals: Articles
  • Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review

    Moss, C. L., Guerrero-Urbano, T., White, I., Taylor, B., Kristeleit, R., Montes, A., Fox, L., Beyer, K., Sztankay, M., Ratti, M. M., Sisca, E. S., Derevianko, A., MacLennan, S., Wood, N., Wintner, L. M., Van Hemelrijck, M.
    Future Oncology, vol. 19, no. 9, pp. 663-678
    Contributions to Journals: Review articles
  • European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

    Nanni, C., Kobe, C., Baeßler, B., Baues, C., Boellaard, R., Borchmann, P., Buck, A., Buvat, I., Chapuy, B., Cheson, B. D., Chrzan, R., Cottereau, A., Dührsen, U., Eikenes, L., Hutchings, M., Jurczak, W., Kraeber-Bodéré, F., Lopci, E., Luminari, S., MacLennan, S., Mikhaeel, N. G., Nijland, M., Rodríguez-Otero, P., Treglia, G., Withofs, N., Zamagni, E., Zinzani, P. L., Zijlstra, J. M., Herrmann, K., Kunikowska, J.
    The Lancet. Haematology, vol. 10, no. 5, pp. e367-e381
    Contributions to Journals: Review articles
  • Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

    MacLennan, S., Pereira-Azevedo, N., Duncan, E., Dunsmore, J., Fullwood, L., Lumen, N., Plass, K., Ribal, M. J., Roobol, M. J., Niebor, D., Schouten, N., Skolarus, T. A., Smith, E. J., N'Dow, J., Mottet, N., Briganti, A., Pan-European National Urological Society IMAGINE Collaborative
    European Urology, vol. 83, no. 5, pp. 393-401
    Contributions to Journals: Articles
  • Best current practice and research priorities in active surveillance for prostate cancer: report of a Movember international consensus meeting

    Moore, C. M., King, L. E., Withington, J., Amin, M. B., Andrews, M., Briers, E., Chen, R. C., Chinegwundoh, F. I., Cooperberg, M. R., Crowe, J., Finelli, A., Fitch, M. I., Frydenberg, M., Giganti, F., Haider, M. A., Haider, M. A., Gallo, J., Gibbs, S., Henry, A., James, N., Kinsella, N., Lam, T., Lichty, M., Loeb, S., Mahal, B. A., Mastris, K., Mitra, A. V., Merriel, S. W. D., van der Kwast, T. H., Van Hemelrijck, M., Palmer, N. R., Paterson, C., Roobol, M. J., Segal, P., Schraidt, J. A., Short, C. E., Siddiqu, M. M., Tempany, C. M. C., Villers, A., Wolinsky, H., MacLennan, S.
    European Urology Oncology, vol. 6, no. 2, pp. 160-182
    Contributions to Journals: Articles
  • How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

    Siltari, A., Lönnerbro, R., Pang, K., Shiranov, K., Asiimwe, A., Evans-Axelsson, S., Franks, B., Kiran, A., Murtola, T. J., Schalken, J., Steinbeisser, C., Bjartell, A., Auvinen, A., N'Dow, J., Smith, E. J., Shepherd, R., Ribal, M., Mottet, N., Moris, L., Lardas, M., Willemse, P. P., Gandaglia, G., Campi, R., Nicoletti, R., Gacci, M., Briganti, A., Ratti, M. M., Alleva, E., Leardini, L., Sisca, E. S., Bangma, R., Roobol, M., Remmers, S., Tilki, D., Visakorpi, T., Talala, K., Tammela, T., van Hemelrijck, M., Bayer, K., Lejeune, S., Byrne, S., Fialho, L., De Meulder, P. P. B., Auffray, C., Hijazy, A., Power, S., Kermani, N. Z., van Bochove, K., MacLennan, S., Tripathee, S., PIONEER Consortium
    Clinical genitourinary cancer, vol. 21, no. 2, pp. 316.e1-316.e11
    Contributions to Journals: Review articles
  • PD16-05 A SYSTEMATIC REVIEW TO EVALUATE PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR METASTATIC PROSTATE CANCER ACCORDING TO THE COSMIN METHODOLOGY: A PIONEER WP2 PROJECT

    Monica, R. M., Giorgio, G., Silvia, S. E., Alexandra, D., Eugenia, A., Katharina, B., Moss, C., Barletta, F., Scuderi, S., Stabile, A., Mazzone, E., Omar, M. I., Maclennan, S., Williamson, P. R., Zong, J., Maclennan, S., Mottet, N., Cornford, P., Lee Aiyegbusi, O., Van Hemelrijck, M., N’Dow, J., Montorsi, F., Briganti, A.
    AUA 2023, pp. e491
    Contributions to Journals: Abstracts
  • Study protocol: transurethral REsection and Single instillation intravesical chemotherapy Evaluation in bladder Cancer Treatment (RESECT). A multi-centre international observational study with embedded cluster randomised trial of audit, feedback and education.

    Gallagher, K., Bhatt, N., Clement, K., Zimmermann, E., Khadhouri, S., MacLennan, S., Kulkarni, M., Gaba, F., Anbarasan, T., Asif, A., Light, A., Ng, A., Chan, V., Nathan, A., Cooper, D., Aucott, L., Marcq, G., TEOH, J. Y., Hensley, P., Duncan, E., Goulao, B., O'Brien, T., Nielsen, M., Mariappan, P., Kasivisvanathan, V.
    JMIR Research Protocols
    Contributions to Journals: Articles
  • How can we improve patient-clinician communication in men diagnosed with prostate cancer?: PA04

    Beyer, K., Lawlor, A., Remmers, S., Venderbos, L. D., Willemse, P. M., Omar, M. I., Smith, E. J., Bezuidenhout, C., Collette, L., MacLennan, S., MacLennan, S., Evans-Axelsson, S., N'Dow, J., Roobol, M. J., Van Hemelrijck, M., Briers, E.
    23rd International Meeting of the European Association of Urology Nurses
    Contributions to Conferences: Abstracts
  • How can we improve patient-clinician communication in men diagnosed with prostate cancer?

    Beyer, K., Lawlor, A., Remmers, S., Venderbos, L. D., Willemse, P. M., Omar, M. I., Smith, E. J., Bezuidenhout, C., Collette, L., MacLennan, S., MacLennan, S., Evans-Axelsson, S., N'Dow, J., Roobol, M. J., Van Hemelrijck, M., Briers, E.
    38th Annual EAU Congress
    Contributions to Conferences: Abstracts
  • A systematic review of heterogeneity in outcome definition and reporting in localised renal cancer

    Beyer, K., Widdershoven, C., Wintner, L. M., Dabestani, S., Marconi, L., Moss, C., Kinsella, N., Yuan, Y., Giles, R. H., Barod, R., Van Hemelrijck, M., Bex, A., Zondervan, P., MacLennan, S.
    European Urology Open Science, vol. 48, pp. 1-11
    Contributions to Journals: Articles
  • A BURST-BAUS consensus document for best practice in the conduct of scrotal exploration for suspected testicular torsion: the Finding consensus for orchIdopeXy In Torsion (FIX-IT) study

    Clement, K. D., Light, A., Asif, A., Chan, V. W., Khadhouri, S., Shah, T. T., Banks, F., Dorkin, T., Driver, C. P., During, V., Fraser, N., Johnston, M. J., Lucky, M., Modgil, V., Muneer, A., Parnham, A., Pearce, I., Shabbir, M., Shenoy, M., Summerton, D. J., Undre, S., Williams, A., MacLennan, S., Kasivisvanathan, V., FIX-IT collaborators
    BJU International, vol. 130, no. 5, pp. 662-670
    Contributions to Journals: Articles
  • EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy

    Fanti, S., Brigantii, A., Emmett, L., Fizazi, K., Gillessen, S., Goffin, K., Hadaschik, B. A., Herrmann, K., Kunikowska, J., Maurer, T., MacLennan, S., Mottet, N., Murphy, D. G., Oprea-Lager, D. E., O’Sullivan, J. M., Oyen, W. J., Rouvière, O., Sartor, O., Stenzl, A., Van Poppel, H., Walz, J., Witjes, W., Bjartell, A.
    European Urology Oncology, vol. 5, no. 5, pp. 530-536
    Contributions to Journals: Articles
  • A Systematic Review to Evaluate Patient-Reported Outcomes Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-based Standard for the selection of Health Measurement INstruments (COSMIN) Methodology

    Ratti, M. M., Gandaglia, G., Sisca, E. S., Derevianko, A., Alleva, E., Beyer, K., Moss, C., Barletta, F., Scuderi, S., Omar, M. I., MacLennan, S., Williamson, P. R., Zong, J., MacLennan, S., Mottet, N., Cornford, P., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Brigantic, A.
    Cancers, vol. 14, no. 20, 5120
    Contributions to Journals: Articles
  • Improving guideline adherence in urology

    MacLennan, S., Duncan, E., Skolarus, T. A., Roobol, M. J., Kasivisvanathan, V., Gallagher, K. M., Gandaglia, G., Sakalis, V., Smith, E. J., Plass, K., Ribal, M. J., N'Dow, J., Briganti, A.
    European Urology Focus, vol. 8, no. 5, pp. 1545-1552
    Contributions to Journals: Review articles
  • Reply to Ruobing Lei, Yuehuan Li, and Yaolong Chen's Letter to the Editor re Katharina Beyer, Lisa Moris, Michael Lardas, et al. Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium. Eur Urol 2022;81:503-14. Improving the Methodological Quality of Prostate Cancer Core Outcome Sets in Future Updates

    Beyer, K., MacLennan, S., Van Hemelrijck, M.
    European Urology, vol. 82, no. 3, pp. e68-e69
    Contributions to Journals: Letters
  • Secondary Treatment for Men with Localized Prostate Cancer: a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platform

    Beyer, K., Straten, V., Remmers, S., MacLennan, S., Gandaglia, G., Willemse, P. M., Herrera, R., Omar, M. I., Russell, B., Huber, J., Kreuz, M., Asiimwe, A., Abbott, T., Briganti, A., Vanhemelrijck, M., Roobol, M. J., MacLennan, S., The PRIAS Consortium, , The ERSPC Rotterdam Study Group, , The PIONEER Consortium,
    Journal of Personalized Medicine, vol. 12, no. 5, 751
    Contributions to Journals: Articles
  • Updating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer: an update from the PIONEER Consortium

    Beyer, K., Moris, L., Lardas, M., Omar, M. I., Healey, J., Tripatheed, S., Gandaglia, G., Venderbos, L. D., Vradi, E., van den Broeck, T., Willemse, P. M., Antunes-Lopes, T., Pacheco-Figueiredo, L., Monagas Arteaga, S., Esperto, F., Flaherty, S., Devecseri, Z., Lam, T., Williamson, P. R., Heer, R., Smith, E. J., Asiimwe, A., Huber, J., Roobol, M. J., Zong, J., Mason, M. D., Cornford, P., Mottet, N., MacLennan, S., N'Dow, J., Brigantii, A., MacLennan, S., Van Hemelrijck, M., PIONEER Consortium
    European Urology, vol. 81, no. 5, pp. 503-514
    Contributions to Journals: Articles
  • Diagnostic and prognostic factors in patients with prostate cancer: a systematic review

    Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Molnar, M., Herrera, R., Rauf, A., Campi, R., Greco, I., Shiranov, K., Dabestani, S., van den Broeck, T., Sujenthiran, A., Gacci, M., Gandaglia, G., Omar, M. I., MacLennan, S., Roobol, M. J., Farahmand, B., Vradi, E., Devecseri, Z., Asiimwe, A., Zong, J., MacLennan, S., Collette, L., N'Dow, J., Briganti, A., Bjartell, A., Van Hemelrijck, M., PIONEER Consortium
    BMJ Open, no. 12, e058267
    Contributions to Journals: Articles
  • Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy

    Willemse, P. M., Davis, N. F., Grivas, N., Zattoni, F., Lardas, M., Briers, E., Cumberbatch, M. G., De Santis, M., Dell'Oglio, P., Donaldson, J. F., Fossati, N., Gandaglia, G., Gillessen, S., Grummet, J. P., Henry, A. M., Liew, M., MacLennan, S., Mason, M. D., Moris, L., Plass, K., O'Hanlon, S., Omar, M. I., Oprea-Lager, D. E., Pang, K. H., Paterson, C., Ploussard, G., Rouvière, O., Schoots, I. G., Tilki, D., van den Bergh, R. C., van den Broeck, T., van der Kwast, T. H., van der Poel, H. G., Wiegel, T., Yuan, C. Y., Cornford, P., Mottet, N., Lam, T. B.
    European Urology, vol. 81, no. 4, pp. 337-346
    Contributions to Journals: Articles
  • Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review

    Ratti, M. M., Gandaglia, G., Alleva, E., Leardini, L., Sisca, E. S., Derevianko, A., Furnari, F., Mazzoleni Ferracini, S., Beyer, K., Moss, C., Pellegrino, F., Sorce, G., Barletta, F., Scuderi, S., Omar, M. I., MacLennan, S., Williamson, P. R., Zong, J., MacLennan, S. J., Mottet, N., Cornford, P., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Briganti, A., The PIONEER Consortium
    European Urology Oncology, vol. 5, no. 2, pp. 153-163
    Contributions to Journals: Articles
  • Outcomes of importance to men with advanced prostate cancer:: PIONEER interview study

    Tripathee, S., Healey, J., Beyer, K., Venderbos, L. D., Van Hemelrijck, M., Roobol, M. J., Huber, J., Smith, E. J., Omar, M. I., N'Dow, J., MacLennan, S., MacLennan, S., PIONEER Consortium
    37th Annual Congress of the European Association of Urology, S1550
    Contributions to Journals: Abstracts
  • Orchidopexy for Testicular Torsion: A Systematic Review of Surgical Technique

    Moore, S. L., Chebbout, R., Cumberbatch, M., Bondad, J., Forster, L., Hendry, J., Lamb, B., MacLennan, S., Nambiar, A., Shah, T. T., Stavrinides, V., Thurtle, D., Pearce, I., Kasivisvanathan, V.
    European Urology Focus, vol. 7, no. 6, pp. 1493-1503
    Contributions to Journals: Review articles
  • EVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY

    Ratti, M. M., Gandaglia, G., Leardini, L., Ferracini, S. M., Sisca, E. S., Derevianko, A., Furnari, S., Beyer, K., Pellegrino, F., Sorce, G., Scuderi, S., Barletta, F., Cucchiara, V., Omar, M. I., Maclennan, S., Zong, J., Maclennan, S. J., Aiyegbusi, O. L., Van Hemelrijck, M., N'Dow, J., Montorsi, F., Briganti, A.
    Journal of Urology, vol. 206, no. S3, pp. E212-E212
    Contributions to Journals: Abstracts
  • What influences adherence to guidance for post-operative instillation of intravesical chemotherapy to bladder cancer patients?

    Dunsmore, J., Duncan, E., Mariappan, P., de Bruin, M., MacLennan, S., Dimitropoulos, K., Kasivisvanathan, V., Mostafid, H., Briganti, A., N'Dow, J., MacLennan, S.
    BJU International, vol. 128, no. 2, pp. 225-235
    Contributions to Journals: Articles
  • Is There Outcome Reporting Heterogeneity in Trials That Aim to Assess the Effectiveness of Surgical Treatments for Stress Urinary Incontinence in Women?

    Cheung, F. Y., Farag, F., MacLennan, S., Yuan, Y., Nambiar, A., Omar, M. I.
    European Urology Focus, vol. 7, no. 4, pp. 857-868
    Contributions to Journals: Review articles
  • The need for core outcome sets in urological cancer research

    MacLennan, S., Williamson, P. R.
    Translational andrology and urology, vol. 10, no. 6, pp. 2832-2835
    Contributions to Journals: Editorials
  • Diagnostic and prognostic factors in patients with prostate cancer

    Beyer, K., Moris, L., Lardas, M., Haire, A., Barletta, F., Scuderi, S., Molnar, M., Herrera, R., Rauf, A., Campi, R., Greco, I., Shiranov, K., Dabestani, S., Van den Broeck, T., Gacci, M., Gandaglia, G., Omar, M. I., Maclennan, S., Roobol, M. J., Zong, J., Maclennan, S., Collette, L., Briganti, A., Bjartell, A., Van Hemelrijck, M., PIONEER Consortium
    EAU21 Virtual Congress, pp. S428-S429
    Contributions to Journals: Abstracts
  • Evaluating Patient-Reported Outcomes Measures (PROMs) for localised prostate cancer: A systematic review using the Consensus-based Standard for the selection of health Measurement Instruments (COSMIN) methodology

    Ratti, M. M., Gandaglia, G., Leardini, L., Mazzoleni, F. S., Sisca, E. S., Derevianko, A., Furnari, S., Beyer, K., Pellegrino, F., Sorce, G., Scuderi, S., Barletta, F., Cucchiara, V., Omar, M. I., Maclennan, S., Zong, J., Maclennan, S. J., Aiyegbusi, O. L., Van Hemelrijck, M., N'dow, J., Montorsi, F., Briganti, A., PIONEER Study Group
    EAU21 Virtual Congress, pp. S430-S431
    Contributions to Journals: Abstracts
  • Secondary treatment for men with localized prostate cancer: A pooled analysis of PRIAS and ERSPC-Rotterdam datasets within the PIONEER data platform

    Beyer, K., Remmers, S., Straten, V., Maclennan, S., Maclennan, S., Willemse, P. P., Herrera, R., Omar, M. I., Russell, B., Huber, J., Kreuz, M., Abbott, T., Asiimwe, A., Briganti, A., Van Hemelrijck, M., Roobol, M. J., PIONEER Consortium
    EAU21 Virtual Congress, pp. S1480-S1481
    Contributions to Journals: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Books and Reports

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Working Papers